These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
334 related items for PubMed ID: 32065344
1. Prognostic significance of sentinel node biopsy status in cutaneous melanoma: a 21-years prospective study from a single institution. Avilés-Izquierdo JA, Nieto-Benito LM, Lázaro-Ochaita P, Escat-Cortés JL, Marquez-Rodas I, Mercader-Cidoncha E. Clin Transl Oncol; 2020 Sep; 22(9):1611-1618. PubMed ID: 32065344 [Abstract] [Full Text] [Related]
2. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients. Speijers MJ, Bastiaannet E, Sloot S, Suurmeijer AJ, Hoekstra HJ. Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514 [Abstract] [Full Text] [Related]
3. Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution. Roulin D, Matter M, Bady P, Liénard D, Gugerli O, Boubaker A, Bron L, Lejeune FJ. Eur J Surg Oncol; 2008 Jun; 34(6):673-9. PubMed ID: 17825518 [Abstract] [Full Text] [Related]
4. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients]. de Vries M, Jager PL, Suurmeijer AJ, Plukker JT, van Ginkel RJ, Hoekstra HJ. Ned Tijdschr Geneeskd; 2005 Aug 13; 149(33):1845-51. PubMed ID: 16128183 [Abstract] [Full Text] [Related]
5. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma. Wagner JD, Ranieri J, Evdokimow DZ, Logan T, Chuang TY, Johnson CS, Jung SH, Wenck S, Coleman JJ. Plast Reconstr Surg; 2003 Aug 13; 112(2):486-97. PubMed ID: 12900606 [Abstract] [Full Text] [Related]
6. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience. Fairbairn NG, Orfaniotis G, Butterworth M. J Plast Reconstr Aesthet Surg; 2012 Oct 13; 65(10):1396-402. PubMed ID: 22552263 [Abstract] [Full Text] [Related]
7. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma. van Akkooi AC, de Wilt JH, Verhoef C, Graveland WJ, van Geel AN, Kliffen M, Eggermont AM. Eur J Cancer; 2006 Feb 13; 42(3):372-80. PubMed ID: 16403622 [Abstract] [Full Text] [Related]
8. Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma. Yamamoto M, Fisher KJ, Wong JY, Koscso JM, Konstantinovic MA, Govsyeyev N, Messina JL, Sarnaik AA, Cruse CW, Gonzalez RJ, Sondak VK, Zager JS. Cancer; 2015 May 15; 121(10):1628-36. PubMed ID: 25677366 [Abstract] [Full Text] [Related]
9. Sentinel node for malignant melanoma: An observational study of a consecutive single centre experience. Belgrano V, Katsarelias D, Mattsson J, Olofsson Bagge R. Eur J Surg Oncol; 2019 Feb 15; 45(2):225-230. PubMed ID: 30391091 [Abstract] [Full Text] [Related]
10. Recurrence factors in patients with cutaneous melanoma and positive sentinel lymph node treated in a single reference unit in Buenos Aires. Nardi WS, Toffolo Pasquini M, Tomé F, Vigovich F, Cora MF, Quildrian SD. Medicina (B Aires); 2024 Feb 15; 84(2):279-288. PubMed ID: 38683513 [Abstract] [Full Text] [Related]
11. Desmoplastic melanoma: The role of pure and mixed subtype in sentinel lymph node biopsy and survival. Laeijendecker AE, El Sharouni MA, Sigurdsson V, van Diest PJ. Cancer Med; 2020 Jan 15; 9(2):671-677. PubMed ID: 31804771 [Abstract] [Full Text] [Related]
12. Is sentinel lymph node biopsy of therapeutic relevance for melanoma? Möhrle M, Schippert W, Rassner G, Garbe C, Breuninger H. Dermatology; 2004 Jan 15; 209(1):5-13. PubMed ID: 15237261 [Abstract] [Full Text] [Related]
13. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma. Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W. Ann Surg Oncol; 2006 Dec 15; 13(12):1655-63. PubMed ID: 17016755 [Abstract] [Full Text] [Related]
14. The role of sentinel lymph node biopsy in patients with local recurrence or in-transit metastasis of melanoma. Gipponi M, Solari N, Giovinazzo D, Queirolo P, Bertoglio S, Villa G, Gualco M, Bleidl D, Cafiero F. Anticancer Res; 2014 Jun 15; 34(6):3197-203. PubMed ID: 24922694 [Abstract] [Full Text] [Related]
15. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma. Murali R, Haydu LE, Quinn MJ, Saw RP, Shannon K, Spillane AJ, Stretch JR, Thompson JF, Scolyer RA. Ann Surg; 2012 Jan 15; 255(1):128-33. PubMed ID: 21975320 [Abstract] [Full Text] [Related]
16. Sentinel node status predicts survival in thick melanomas: the Oxford perspective. Rughani MG, Swan MC, Adams TS, Marshall A, Asher R, Cassell OC, Middleton MR. Eur J Surg Oncol; 2012 Oct 15; 38(10):936-42. PubMed ID: 22617251 [Abstract] [Full Text] [Related]
17. Clinico-pathological features of patients with melanoma and positive sentinel lymph node biopsy: a single institution experience. Homolak D, Šitum M, Čupić H. Acta Dermatovenerol Croat; 2015 Oct 15; 23(2):122-9. PubMed ID: 26228823 [Abstract] [Full Text] [Related]
18. Nodal and systemic recurrence following observation of a positive sentinel lymph node in melanoma. Bartlett EK, Lee AY, Spanheimer PM, Bello DM, Brady MS, Ariyan CE, Coit DG. Br J Surg; 2020 Oct 15; 107(11):1480-1488. PubMed ID: 32484242 [Abstract] [Full Text] [Related]